论文部分内容阅读
目的:探讨布地奈德雾化吸入用于儿童咳嗽变异性哮喘的治疗效果。方法:选取104名患有咳嗽变异性哮喘的儿童作为研究对象,随机分为观察组和对照组,各52例。对照组进行常规治疗,观察组在常规治疗的基础上进行布地奈德雾化吸入治疗。比较两组儿童患者治疗的有效率、症状缓解情况及复发情况。结果:观察组患儿临床症状缓解时间和消失时间均低于对照组(P<0.05);观察组治疗总有效率为92.30%,对照组为76.92%,观察组总有效率高于对照组(P<0.05);观察组复发率为9.61%,对照组为23.07%,观察组复发率低于对照组(P<0.05),差异均具有统计学意义。结论:采用布地奈德雾化吸入治疗儿童咳嗽变异性哮喘,复发率低,效果显著,值得推广应用。
Objective: To investigate the therapeutic effect of budesonide inhalation for children with cough variant asthma. Methods: Totally 104 children with cough variant asthma were randomly divided into observation group and control group, with 52 cases in each group. The control group was treated routinely, and the observation group received budesonide inhalation therapy on the basis of routine treatment. Efficacy, symptom relief and recurrence of children in two groups were compared. Results: The remission time and disappearance time of clinical symptoms in the observation group were lower than those in the control group (P <0.05). The total effective rate was 92.30% in the observation group and 76.92% in the control group, and the total effective rate in the observation group was higher than that in the control group P <0.05). The recurrence rate was 9.61% in the observation group and 23.07% in the control group, and the recurrence rate in the observation group was lower than that in the control group (P <0.05). The differences were statistically significant. Conclusion: The use of budesonide inhalation in children with cough variant asthma, low recurrence rate, the effect is significant, it is worth popularizing and applying.